Ebastine + Montelukast in pharma franchise in Meghalaya

Ebastine + Montelukast in PCD pharma franchise in Shimla

Ebastine + Montelukast in top pharma company in Gangtok

Ebastine + Montelukast in pcd pharma supplier in Hubli-Dharwad

Ebastine + Montelukast in phama franchise company in India
Ebastine + Montelukast in phama distributor in Dewas

Home/Products /ebastine-10mg-montelukast-10mg-tablet

Ebatyle M Tablet

Composition : Ebastine (10mg) + Montelukast (10mg)

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10x10

Price : ₹177/-

        Ebatyle M Tablet is a combination medication containing two active ingredients: Ebastine (10mg) and Montelukast (10mg). Ebastine is a second-generation antihistamine, while Montelukast is a leukotriene receptor antagonist. This combination provides effective relief for various allergic and respiratory conditions by targeting different pathways of the body's immune response.

Ebastine works by blocking histamine, a substance that causes allergic symptoms such as itching, sneezing, and watery eyes. Montelukast, on the other hand, prevents the action of leukotrienes, chemicals involved in inflammation and bronchoconstriction, helping to reduce inflammation in the airways and prevent symptoms like wheezing and shortness of breath.

Ebatyle M Tablet is commonly used in the treatment of allergic rhinitis (hay fever) and asthma. It helps manage symptoms like nasal congestion, sneezing, runny nose, and itching in cases of allergic rhinitis. In patients with asthma, the combination of Ebastine and Montelukast works to reduce inflammation and prevent asthma attacks, improving overall lung function and quality of life.

This medication is ideal for individuals with both allergic rhinitis and asthma, offering a dual mechanism of action for managing both conditions simultaneously. It is well-tolerated and provides long-lasting symptom control with a single daily dose.

Read More

About the Product

        Ebatyle M Tablet is a combination medication containing two active ingredients: Ebastine (10mg) and Montelukast (10mg). Ebastine is a second-generation antihistamine, while Montelukast is a leukotriene receptor antagonist. This combination provides effective relief for various allergic and respiratory conditions by targeting different pathways of the body's immune response.

Ebastine works by blocking histamine, a substance that causes allergic symptoms such as itching, sneezing, and watery eyes. Montelukast, on the other hand, prevents the action of leukotrienes, chemicals involved in inflammation and bronchoconstriction, helping to reduce inflammation in the airways and prevent symptoms like wheezing and shortness of breath.

Ebatyle M Tablet is commonly used in the treatment of allergic rhinitis (hay fever) and asthma. It helps manage symptoms like nasal congestion, sneezing, runny nose, and itching in cases of allergic rhinitis. In patients with asthma, the combination of Ebastine and Montelukast works to reduce inflammation and prevent asthma attacks, improving overall lung function and quality of life.

This medication is ideal for individuals with both allergic rhinitis and asthma, offering a dual mechanism of action for managing both conditions simultaneously. It is well-tolerated and provides long-lasting symptom control with a single daily dose.

Common side effects may include headache, dizziness, fatigue, dry mouth, or abdominal discomfort. Serious side effects are rare but may include allergic reactions or changes in mood. If any unusual symptoms occur, consult a healthcare provider.

Allergic rhinitis (hay fever) Asthma (prevention and management)

Not recommended for individuals with hypersensitivity to Ebastine or Montelukast. Use with caution in patients with liver disorders or asthma-related breathing problems.

Store in a cool, dry place, away from direct sunlight. Keep out of the reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation